Glympse Bio

Glympse Bio

Glympse Bio

Transforming disease monitoring for patients, providers, and society. Imagine a future where a simple urine test can detect deadly diseases before they get out of control. A future when diseases can be intercepted and people dont become patients.
Founded
2015
Raised
$68.7M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$46,700,000
Venture capital (Series B) - 2020
CRV ARCH Venture Partners New Leaf Venture Partners +8
Team Size
1–10
Employees
$46,700,000 Venture capital (Series B)
MedCity News , FinSMEs

Glympse Bio raises more than $46M in Series B round for biosensor technology

$22,000,000 Venture capital (Series A)
FinSMEs , PE HUB

Glympse Bio Raises $22m Series A Financing

Funding Science